Osaka University, Graduate School of Engineering, Department of Applied Chemistry, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
Expert Opin Drug Deliv. 2009 Nov;6(11):1207-17. doi: 10.1517/17425240903280414.
One of the key challenges in the field of bio-nanotechnology for drug delivery systems (DDS) is the development of nano- or micro-sized delivery carriers possessing both targeting functionalities for specific tissues or cells, and controlled release properties for encapsulated drug molecules, proteins and genes. Hollow capsules developed by layer-by-layer (LbL) assembly have attracted much attention over the past few years owing to their ability to be modified, their capacity to encapsulate a wide range of chemicals, and the variety of functionalities with which they can be enhanced. Current research on LbL capsules focuses on the development of functionalized capsules for specific targeting of cancer or immune cells, and on controlling their release properties by environmental stimuli. This review discusses recent advances in DDS using functional hollow capsules specific for the cellular and tissue-targeted delivery, as well as stimuli-responsive controlled release. DDS based on functional hollow capsules may contribute to the development of new nano-medicines.
在药物传递系统(DDS)的生物纳米技术领域中,一个关键的挑战是开发具有针对特定组织或细胞的靶向功能的纳米或微米级的传递载体,以及对封装的药物分子、蛋白质和基因具有控制释放特性的载体。近年来,通过层层(LbL)组装开发的中空胶囊因其可修饰性、能够封装广泛的化学物质以及可以增强多种功能而受到广泛关注。目前,关于 LbL 胶囊的研究集中在开发用于特定靶向癌症或免疫细胞的功能化胶囊,以及通过环境刺激来控制其释放特性。本综述讨论了使用针对细胞和组织靶向传递的功能性中空胶囊的 DDS 的最新进展,以及对刺激响应的控制释放。基于功能性中空胶囊的 DDS 可能有助于新型纳米药物的开发。